Home>>Signaling Pathways>> Neuroscience>> Pain Research>>PKI (14-22) amide (myristoylated) (trifluoroacetate salt)

PKI (14-22) amide (myristoylated) (trifluoroacetate salt) Sale

(Synonyms: Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2, Myr-GRTGRRNAI-NH2, Myristoylated PKI-(14-22)-amide, PKI-(Myr-14-22)-amide) 目录号 : GC49265

A PKA inhibitor

PKI (14-22) amide (myristoylated) (trifluoroacetate salt) Chemical Structure

规格 价格 库存 购买数量
500 µg
¥1,525.00
现货
1 mg
¥2,741.00
现货
5 mg
¥8,395.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

PKI (14-22) amide (myristoylated) is a cell-permeable peptide inhibitor of protein kinase A (PKA).1,2,3 It inhibits PKA activity in mouse brain or spinal cord lysates when used at a concentration of 75 µM.1 PKI (14-22) amide (myristoylated) reduces IgG-dependent phagocytosis of heat-killed S. cerevisiae by isolated human neutrophils in a concentration-dependent manner.2 It inhibits the replication of several strains of Zika virus, including IbH 30656, MR766, H/FP/2013, and PRVABC59, in human umbilical vein endothelial cells (HUVECs; IC50s = 17.75, 22.29, 34.09, and 19.19 µM, respectively).3 PKI (14-22) amide (myristoylated) (2.5 nmol, i.c.v.) increases latency to tail withdrawal in the tail-flick test in morphine-tolerant mice.1

1.Dalton, G.D., Smith, F.L., Smith, P.A., et al.Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI)Neuropharmacology48(5)648-657(2005) 2.Ydrenius, L., Majeed, M., Rasmusson, B.J., et al.Activation of cAMP-dependent protein kinase is necessary for actin rearrangements in human neutrophils during phagocytosisJ. Leukoc. Biol.67(4)520-528(2000) 3.Cheng, F., da Silva, S.R., Huang, I.-C., et al.Suppression of Zika virus infection and replication in endothelial cells and astrocytes by PKA inhibitor PKI 14-22J. Virol.92(4)e02019-02017(2018)

Chemical Properties

Cas No. N/A SDF
别名 Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2, Myr-GRTGRRNAI-NH2, Myristoylated PKI-(14-22)-amide, PKI-(Myr-14-22)-amide
Canonical SMILES O=C(CCCCCCCCCCCCC)NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@H](O)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@@H](C)C(N[C@H](C(N)=O)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
分子式 C53H100N20O12·XCF3COOH 分子量 1209.5
溶解度 DMSO: 1 mg/ml,DMSO:PBS (pH 7.2) (1:3): 0.25 mg/ml 储存条件 -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 0.8268 mL 4.1339 mL 8.2679 mL
5 mM 0.1654 mL 0.8268 mL 1.6536 mL
10 mM 0.0827 mL 0.4134 mL 0.8268 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置